EULAR 2023 Onsite in Milan, Italy

We are excited to announce that we will be holding the EULAR 2023 Congress on-site in Milan, Italy as a live event. We are proud to be bringing the congress to this extraordinary city and to once again provide an outstanding, world class programme that will educate, stimulate and inspire in equal measure!

The EULAR congress in Milan will especially focus on live interactions and networking – the essence of the ‘congress experience’ about which so many of you have enthused since our gathering in Copenhagen. By this means, we will nurture the essential partnerships and friendships that unite us in our fight against rheumatic and musculoskeletal diseases. By this means, we will nurture the essential partnerships and friendships that unite us in our fight against rheumatic and musculoskeletal diseases. 

News from Societies

EULAR is delighted to share Rheumatology-related news from other societies in our quest to improve the lives of people with rheumatic and musculoskeletal diseases.

• The British Society for Rheumatology has published new guidelines for the treatment of rheumatic conditions during conception, pregnancy and breastfeeding.

World Arthritis Day 2022: What is your #RheumaPainPoint?

EULAR's WAD 2022 campaign is focused on understanding the issues the diverse audiences have in the field of rheumatology, such as a shrinking medical workforce, long waiting times for appointments, or lacking understanding of RMDs among governmental decision-makers. Better understanding these 'pain points' will allow us to better address them both at a national and international level, which is EULAR's key goal. 

EULAR Press Releases

The latest:

• Updated: RA Treatment Recommendations
• Updated: RA Treatment Recommendations
• Revised: ACR/EULAR Remission Criteria

EULAR Announces Measures to Support Ukraine

EULAR has taken a series of decisions in view of Russia’s government attack on Ukraine

—

The European Alliance of Associations for Rheumatology, EULAR, strongly dissents Russia’s government attack on Ukraine, in violation of Ukraine’s sovereignty, territorial integrity, independence, and the welfare of its residents. As hospitals are being attacked and access to medical aid is interrupted, EULAR wants to respond to this humanitarian crisis and particularly support the Ukrainian people with rheumatic and musculoskeletal diseases (RMDs), who need urgent treatment and assistance.

EULAR Recommendations

Read the latest:

• EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
• EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis